Cytek Biosciences, Inc. Sustainability Profile
Cytek Biosciences, Inc., a leading innovator in the field of flow cytometry, is headquartered in the United States, with significant operations across North America, Europe, and Asia. Founded in 2014, the company has rapidly established itself as a key player in the life sciences industry, focusing on advanced cell analysis technologies. Cytek is renowned for its unique spectral flow cytometry systems, which offer unparalleled sensitivity and resolution, enabling researchers to gain deeper insights into cellular functions. Their flagship products, including the Aurora and Northern Lights systems, are distinguished by their ability to analyse complex samples with high-dimensional data. With a commitment to advancing scientific research, Cytek Biosciences has achieved notable milestones, including rapid growth in market share and recognition for its innovative solutions, solidifying its position as a trusted partner in the global scientific community.
DitchCarbon Score
How does Cytek Biosciences, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cytek Biosciences, Inc.'s score of 25 is lower than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Cytek Biosciences, Inc.'s reported carbon emissions
Cytek Biosciences, Inc., headquartered in the US, currently does not have any reported carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As of now, Cytek Biosciences has not inherited any emissions data from a parent or related organization, nor does it have any cascading climate initiatives from other entities. This lack of data suggests that the company may still be in the early stages of developing its climate commitments or reporting practices. In the context of the industry, it is essential for companies like Cytek Biosciences to establish clear climate goals and emissions reduction strategies to align with global sustainability efforts and meet stakeholder expectations.
How Carbon Intensive is Cytek Biosciences, Inc.'s Industry?
How Carbon Intensive is Cytek Biosciences, Inc.'s Location?
Cytek Biosciences, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Cytek Biosciences, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
